Use-dependent exaggeration of brain injury: Is glutamate involved?

Experimental Neurology

Volumn 157, Issue 2, 1999, Pages 349-358

  Humm, J Leigh ^a   Kozlowski, Dorothy A ^a   Bland, Sondra T ^a   James, Debra C ^a   Schallert, Timothy ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Forelimb use; Glutamate; MK 801; NMDA receptor; Recovery of function; Sensorimotor cortex; Use dependent

Indexed keywords

DIZOCILPINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADOLESCENT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; FORELIMB; HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REHABILITATION; SENSORIMOTOR CORTEX;

EID: 0033012635     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7061     Document Type: Article

References (62)

1. Angel A., Lemon R. N. Sensorimotor cortical representation in the rat and the role of the cortex in the production of sensory myoclonic jerks. J. Physiol. 248:1975;465-488.
2. Barth T. M., Grant M. A., Schallert T. Effects of MK-801 on recovery from sensorimotor cortex lesions. Stroke. 21:1990;1-5.
3. Bielenberg G. W., Beck T. The effects of dizocilpine (MK-801), phencyclidine, and nimodipine on infarct size 48 h after middle cerebral artery occlusion in the rat. Brain Res. 552:1991;338-342.
4. Bland S. T., Johnson M. S., Schallert T., Gonzales R. A. Extra-cellular glutamate and other free amino acids in sensorimotor cortex are related to forelimb use during exploratory behavior. Soc. Neurosci. Abstr. 23:1997;94.9.
5. Boxer P. A., Cordon J. J., Mann M. E., Rodolosi L. C., Vartanian M. G., Rock D. M., Taylor C. P., Marcoux F. W. Comparison of phenytoin with noncompetitive N-methyl-d-aspartate antagonists in a model of focal brain ischemia in the rat. Stroke. 21:1990;47-51.
6. Bullock R., Fujisawa H. The role of glutamate antagonists for the treatment of CNS injury. J. Neurotrauma. 9:1992;S443-S462.
7. Choi D. W., Koh J., Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: Attenuation by NMDA antagonists. J. Neurosci. 8:1988;185-196.
8. Choi D. W., Maulucci-Gedde M., Kriegstein A. R. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7:1987;357-368.
9. Colton C. A., Gilbert D. L. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett. 223:1987;284-288.
10. Day J., Damsma G., Fibiger H. C. Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: An in vivo microdialysis study. Pharmacol. Biochem. Behav. 38:1991;723-729.
11. De Ryck M., Van Reempts J., Duytschaever H., Van Deuren B., Clincke G. Neocortical localization of tactile/proprioceptive limb placing reactions in the rat. Brain Res. 573:1992;44-60.
12. Di X., Harpold T., Watson J. C., Bullock M. R. Excitotoxic damage in neurotrauma: Fact or fiction. Restor. Neurol. Neurosci. 9:1996;231-241.
13. Dietrich W. D., Lin B., Globus M. Y., Green E. J., Ginsberg M. D., Busto R. Effect of delayed MK-801 (dizocilpine) treatment with or without immediate postischemic hypothermia on chronic neuronal survival after global forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 15:1995;960-980.
14. Dimagl U., Tanabe J., Pulsinelli W. Pre- and post-treatment with MK-801 but not pretreatment alone reduces neocortical damage after focal cerebral ischemia in the rat. Brain Res. 527:1990;62-68.
15. Finger S., Hart T., Jones E. Recovery time and sensorimotor cortex lesion effects. Physiol. Behav. 29:1982;73-78.
16. Fix A. S., Horn J. W., Wightman K. A., Johnson C. A., Long G. G., Storts R. W., Farber N., Wozniak D. F., Olney J. W. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-d-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): A light and electron microscopic evaluation of the rat retrosplenial cortex. Exp. Neurol. 123:1993;204-215.
17. Foster A. C., Gill R., Woodruff G. N. Neuroprotective effects of MK-801 in vivo: Selectivity and evidence for delayed degeneration mediated by NMDA receptor activation. J. Neurosci. 8:1988;4745-4754.
18. Giulian D. Ameboid microglia as effectors of inflammation in the central nervous system. J. Neurosci. Res. 18:1987;155-171.
19. Giulian D., Robertson C. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann. Neurol. 27:1990;33-42.
20. Giulian D., Vaca K. Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke. 24:1993;84-90.
21. Giulian D., Corpuz M., Chapman S., Mansouri M., Robertson C. Reactive mononuclear phagocytes release neuron killing factors after stroke and trauma. J. Neurosci. Res. 36:1993;681-693.
22. Giulian D., Li J., Leara B., Keenen C. Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture. Neurochem. Int. 25:1994;227-233.
23. Goldstein L. B. Rapid reliable measurement of lesion parameters for studies of motor recovery after sensorimotor cortex injury in the rat. J. Neurosci. Methods. 48:1993;35-42.
24. Goldstein L. B. Right vs. left sensorimotor cortex suction-ablation in the rat: No differences in beam-walking recovery. Brain Res. 674:1995;167-170.
25. Goldstein L. B., Coviello A. Post-lesion administration of the NMDA receptor antagonist MK-801 does not impair motor recovery after unilateral sensorimotor cortex injury in the rat. Brain Res. 580:1992;129-136.
26. Hargreaves E. L., Cain D. P. Hyperactivity, hyper-reactivity and sensorimotor deficits induced by low doses of the N-methyl-d-aspartate non-competitive channel blocker MK-801. Behav. Brain Res. 47:1992;23-33.
27. Hoane M. R., Irish S. L., Marks B. B., Barth T. M. Preoperative regimens of magnesium facilitate recovery of function and prevent subcortical atrophy following lesions of the rat sensorimotor cortex. Brain Res. Bull. 45:1998;45-51.
28. Humm J. L., Kozlowski D. A., James D. C., Gotts J. E., Schallert T. Use-dependent exacerbation of brain damage occurs during an early post-lesion vulnerable period. Brain Res. 783:1998;286-292.
29. Jones T. A., Schallert T. Overgrowth and pruning of dendrites in adult rats recovering from neocortical damage. Brain Res. 581:1992;156-160.
30. Jones T. A., Schallert T. Use-dependent growth of pyramidal neurons after neocortical damage. J. Neurosci. 14:1994;2140-2152.
31. Kawamata T., Dietrich W. D., Schallert T., Gotts J. E., Cocke R. R., Benowitz L. I., Finklestein S. P. Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc. Natl. Acad. Sci. USA. 94:1997;8179-8184.
32. Keefe K. A., Gerfen C. R. D1 dopamine receptor-mediated induction of zif68 and c-fos in the dopamine-depleted striatum: Differential regulation and independence from NMDA receptors. J. Comp. Neurol. 367:1996;165-176.
33. Kirk R. E. Experimental Design: Procedures for the Behavioral Sciences. 1965;Brooks-Cole, Belmont.
34. Kochar A., Zivin J. A., Lyden P. D. Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. Arch. Neurol. 45:1988;148-153.
35. Kozlowski D. A., Jones T. A., Schallert T. Pruning of dendrites and restoration of function after brain damage: Role of the NMDA receptor. Restor. Neurol. Neurosci. 7:1994;119-126.
36. Kozlowski D. A., James D. C., Schallert T. Use-dependent exaggeration of neuronal injury after unilateral sensorimotor cortex lesions. J. Neurosci. 16:1996;4776-4786.
37. Kozlowski D. A., Hilliard S., Schallert T. Ethanol consumption following recovery from unilateral damage to the forelimb area of the sensorimotor cortex: Reinstatement of deficits and prevention of dendritic pruning. Brain Res. 763:1997;159-166.
38. LeVere T. Recovery of function after brain damage. A theory of the behavioral deficit. Physiol. Psychol. 8:1980;297-308.
39. Lyeth B. G., Hayes R. L. Cholinergic and opioid mediation of traumatic brain injury. J. Neurotrauma. 9:1992;463-474.
40. Michaels R. L., Rothman S. M. Glutamate neurotoxicity in vitro: Antagonist pharmacology and intracellular calcium concentrations. J. Neurosci. 10:1990;283-292.
41. Nudo R. J., Wise B. M., SiFuentes F., Milliken G. W. Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science. 272:1996;791-794.
42. Obrenovitch T. P., Urenjak J. Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury. J. Neurotrauma. 14:1997;677-698.
43. Ogden R., Franz S. I. On cerebral motor control: The recovery from experimentally produced hemiplegia. Psychobiology. 1:1917;33-47.
44. Ostendorf C. G., Wolf S. L. Effect of forced use of the upper extremity of a hemiplegic patient on changes in function. J. Am. Phys. Ther. Assoc. 61:1981;1022-1028.
45. Piani D., Frei K., Do K. Q., Cuenod M., Fontana A. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 133:1991;159-162.
46. Royet J. P. Stereology: A method for analyzing images. Prog. Neurobiol. 37:1991;433-474.
47. Saji M., Reis D. J. Delayed transneuronal death of substantia nigra neurons prevented by gamma-aminobutyric acid agonist. Science. 235:1988;66-69.
48. Saponjic R. M., Hoane M. R., Barbay S., Barth T. M. Scopolamine facilitates recovery of function following unilateral electrolytic sensorimotor cortex lesions in the rat. Restor. Neurol. Neurosci. 8:1995;205-212.
49. Schallert T., Lindner M. D. Rescuing neurons from trans-synaptic degeneration after brain damage: Helpful, harmful, or neutral in recovery of function. Can. J. Psychol. 44:1990;276-292.
50. Schallert T., Kozlowski D. A., Humm J. L., Cocke R. R. Use-dependent structural events in recovery of function. Freund H-J., Sabel B. A., Witte O. W. Advances in Neurology, Vol. 73, Brain Plasticity. 1996;229-238 Lippincott-Raven, Philadelphia.
51. Schallert T., Hernandez T. D. GABAergic drugs and neuroplasticity after brain injury: Impact on functional recovery. Goldstein L. B. Restorative Neurology: Advances in Pharmacotherapy for Recovery after Stroke. 1998;91-120 Futura, Armonk.
52. Schmanke T., Barth T. M. Amphetamine and task-specific practice augment recovery of vibrissae-evoked forelimb placing after unilateral sensorimotor cortical injury in the rat. J. Neurotrauma. 14:1997;459-468.
53. Soblosky J. S., Matthews M. A., Davidson J. F., Tabor S. L., Carey M. E. Traumatic brain injury of the forelimb and hindlimb sensorimotor areas in the rat: Physiological, histological and behavioral correlates. Behav. Brain Res. 79:1996;79-92.
54. Soblosky J. S., Colgin L. L., Chorney-Lane D., Davidson J. F., Carey M. E. Some functional recovery and behavioral sparing occurs independent of task-specific practice after injury to the rat's sensorimotor cortex. Behav. Brain Res. 89:1997;51-59.
55. Taub E., Miller N. E., Novack T. A., Cook E. W., Fleming W. C., Nepomuceno C. S., Connell J. S., Crago J. E. Technique to improve chronic motor deficit after stroke. Arch. Phys. Med. Rehab. 74:1993;347-354.
56. Tecoma E. S., Monyer H., Goldberg M. P., Choi D. W. Traumatic neuronal injury in vitro is attenuated by NMDA antagonists. Neuron. 2:1989;1541-1545.
57. Thanos S., Mey J., Wild M. Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J. Neurosci. 13:1993;455-466.
58. Uylings H. B. M., VanEden C. G., Hoffman M. A. Morphometry of size/volume variables and comparison of their bivariate relations in the nervous system under different conditions. J. Neurosci. Methods. 18:1986;19-37.
59. Vanderwolf C. H. Cerebral activity and behavior: Control by central cholinergic and serotonergic systems. Int. Rev. Neurobiol. 30:1988;225-340.
60. Webster H. H., Hanish U-K., Dykes R. W., Biesold D. Basal forebrain lesions with or without reserpine injection inhibit cortical reorganization in rat hindpaw primary somatosensory cortex following sciatic nerve section. Somatosens. Mot. Res. 3:1991;327-346.
61. Whishaw I. Q., Coles B. L. Varieties of paw and digit movement during spontaneous food handling in rats: Postures, bimanual coordination, preferences, and the effect of forelimb cortex lesions. Behav. Brain Res. 77:1996;135-148.
62. Wolf S. L., Lecraw D. E., Barton L. A., Jann B. B. Forced use of hemiplegic upper extremities to reverse the effect of learned nonuse among chronic stroke and head-injured patients. Exp. Neurol. 104:1989;125-132.